V Kalbermatter, D Bagilet, M Diab, E Javkin - Medicina clinica, 2000 - europepmc.org
Background Levofloxacin, an antibiotic from the quinolone family, which is used with success in the ambulatory treatment of patients with community-acquired pneumonia, has …
S Moola, L Hagberg, GA Churchyard, JS Dylewski… - Chest, 1999 - Elsevier
Study objectives To compare the efficacies of 10-day regimens of grepafloxacin (GFX)(Raxar or Vaxar; Glaxo Wellcome; Greenford, UK), 600 qd, and clarithromycin …
MH Gotfried, D Dattani, E Riffer, KJ Devcich… - Clinical …, 2002 - Elsevier
Background: Macrolides and fluoroquinolones are frequently used for the empiric treatment of community-acquired pneumonia (CAP). Objective: The aim of the study was to compare …
Background Community acquired pneumonia (CAP) is a major cause of morbidity, hospitalization, and mortality worldwide. Management of CAP for many patients requires …
V Erard, O Lamy, PY Bochud, J Bille, A Cometta… - European Journal of …, 2004 - Springer
Most guidelines for the management of hospitalized patients with community-acquired pneumonia (CAP) recommend commencing therapy with intravenous antibiotics, primarily …
Background Community‐acquired pneumonia (CAP) is a lung infection that can be acquired during day‐to‐day activities in the community (not while receiving care in a hospital) …
G Waterer, L Bennett - Current Opinion in Pulmonary Medicine, 2015 - journals.lww.com
To achieve best outcomes for their patients, physicians must be actively comparing their outcomes against other institutions and not rely on historical data. A bundle of care that …
S McCurdy, K Keedy, L Lawrence… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
Delafloxacin is a novel fluoroquinolone with activity against Gram-positive, Gram-negative, and atypical pathogens, including fluoroquinolone-nonsusceptible methicillin-resistant …
A Tessmer, T Welte, P Martus, M Schnoor… - Journal of …, 2009 - academic.oup.com
Objectives Guidelines recommend dual-therapy consisting of a β-lactam/macrolide (BLM) for hospitalized patients with community-acquired pneumonia. Nevertheless, the superiority …